Who we are
Radcliffe Vascular is a dynamic, digitally-focused producer & publisher of vascular content for physicians worldwide. We aim to assist in the continuous education of physicians within the vascular fraternity, generating a range of clinical content through collaboration with leading vascular surgeons from around the globe.
Why we exist
To continually push the boundaries of cardiovascular education through collaboration with global innovation leaders.
To become the most respected digital resource of independent, expert-led cardiovascular education through the provision of a personalised learning experience.
Our Journals & Content
Alongside our digital and multimedia content, we provide access to the latest academic research via an open access platform and produce independent peer-reviewed content through the following industry-leading review journals:
- Vascular & Endovascular Review (VER) – Launching in Sept 2018
- Arrhythmia & Electrophysiology Review (AER)
- Cardiac Failure Review (CFR)
- European Cardiology Review (ECR)
- Interventional Cardiology Review (ICR)
- US Cardiology Review (USC)
Radcliffe Vascular also has a dedicated eLearning platform, RV Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions which help our community of 75,000 vascular professionals keep up-to-date with the latest opinion, guidance and innovation in cardiovascular medicine.
Our journals are tri or bi-annual and comprise review articles that summarize and critique original research; provide editorials, expert opinion pieces and in some cases, meta-analyses.
Each journal is supported by a Peer Review Board of over 100 leading physicians and healthcare professionals from across the vascular fraternity. Comprehensive bibliographies for each article mean that all issues are informative and can be used as valuable reference tools and may be found indexed in PubMed, CrossRef and Scopus.
We endeavour to publish unbiased, balanced articles and follow the recommendations provided by the ICMJE and the Good Publication Practice (GPP3) guidelines. Please refer to our Instructions for Authors document here for further detail.
Our peer review process
To ensure accuracy of published content within our journals, all articles are subject to a double-blind peer review. Reviewers are selected based on their clinical expertise and are recognised authorities within the field. Following review, a reviewer either advises that an article is accepted without revision, or that either minor or major revisions are required to ensure an article presents a balanced, accurate and clinically-robust overview of the topic in question. An article may be rejected outright if it is deemed structurally flawed. Any revisions requested by the review are communicated to the author, and once incorporated, the article is sent to the journal’s Editor-in-Chief for secondary review. Where there are any points of contention between author and primary reviewer, the Editor-in-Chief will adjudicate. An article is only accepted for publication following approval by the Editor-in-Chief.
Our funding model
Radcliffe Vascular provides free educational content to vascular and allied healthcare professionals. The vast majority of our content is editorially independent, developed at our own cost.
However, to keep the platform a free resource, from time-to-time we do collaborate and receive funding from select industry partners in the following ways and all sources of such funding are fully declared on all these materials:
- Print and eBook adverts at the front and back of the journals (never within the journal text)
- Web banner advertising
- Interstitial adverts
- Pre-roll video adverts (as pre-cursors to our independent content)
- Promotional/supplemental content (published as supplements to our peer-reviewed journals)
- Supported webinars, roundtable discussions, video interviews and live cases
- Continuing Medical Education (CME) activities
Radcliffe Vascular does not under any circumstances charge any author fees for publication of manuscripts in our family of journals.
Radcliffe Vascular is a STM full member. STM is the leading global trade association for academic and professional publishers. It has over 120 members in 21 countries who each year collectively publish nearly 66% of all journal articles and tens of thousands of monographs and reference works. STM members include learned societies, university presses, private companies, new starts and established players.
Radcliffe Vascular is a member of CrossRef, a not-for-profit organization that makes scholarly publishing content easy to find, cite, link and assess. It doesn’t provide a link to full text scientific content but is rather a collaborative reference linking service to facilitate the search function for researchers.
Radcliffe Vascular is an independent publisher and a limited company. We are not affiliated or an agent of the Oxford Heart Centre, John Radcliffe Hospital or Oxford University Hospitals NHS Foundation Trust group.
Radcliffe Group Ltd, Unit F, First Floor, Bourne End Business Park, Cores End Road, Buckinghamshire, SL8 5AS.
Registered in England and Wales: No. 8772497